New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 16, 2014
08:01 EDTFRX, RGLSRegulus Therapeutics appoints Paul Grint as Chief Medical Officer
Grint joined Regulus from Cerexa, a wholly-owned subsidiary of Forest Laboratories.
News For RGLS;FRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 24, 2014
10:00 EDTRGLSOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:00 EDTRGLSRegulus Therapeutics initiated with a Buy at Deutsche Bank
Subscribe for More Information
November 19, 2014
08:59 EDTRGLSRegulus Therapeutics data positive, says Wedbush
Subscribe for More Information
November 16, 2014
14:44 EDTRGLSRegulus, Sanofi present new data enhancing the preclinical profile of RG-012
Subscribe for More Information
November 13, 2014
10:27 EDTRGLSHigh option volume stocks
Subscribe for More Information
07:54 EDTRGLSRegulus Therapeutics 2M share Block Trade priced at $18.25
Morgan Stanley acted as sole book running manager for the offering.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use